Patient Advocates Enlist Senate In Fighting TPP Drug Pricing Provisions

September 26, 2014 at 12:43 PM
U.S. patient advocate groups and labor unions are ratcheting up their effort to convince the Obama administration to back away from provisions it has proposed in the Trans-Pacific Partnership (TPP) negotiations that the groups fear could help multinational drug companies drive up pharmaceutical prices under public health programs in the United States. These groups -- which include the American Association of Retired Persons (AARP) and the American Federation of State, County and Municipal Employees (AFSCME) -- are urging senators to...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.